Effectiveness of Osteoporosis Drug in Postmenopausal Women with Spinal Compression Fracture: Combined Consecutive Therapy of Teriparatide and Raloxifene versus Bisphosphonate Single

OBJECTIVE: Bisphosphonate, a typical bone resorption inhibitor, is an important first-line drug for treating osteoporosis. Recent studies show a novel paradigm in stimulating bone formation. Teriparatide, which is composed of recombinant human parathyroid hormone, stimulates osteoblasts and induces...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Chang Jin, Kim, Sion, Choi, Chun Sik, Shin, Hyun Chul, Kwon, Young Joon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Neurotraumatology Society 2016
Materias:
Clinical Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5110901/
https://www.ncbi.nlm.nih.gov/pubmed/27857920
http://dx.doi.org/10.13004/kjnt.2016.12.2.123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5110901/
https://www.ncbi.nlm.nih.gov/pubmed/27857920
http://dx.doi.org/10.13004/kjnt.2016.12.2.123

Ejemplares similares